|
Telotristat Etiprate
|
4-[2-氨基-6-[(1R)-1-[4-氯-2-(3-甲基-1H-吡唑-1-基)苯基]-2,2,2-三氟乙氧基]-4-嘧啶基]-L-苯丙氨酸乙酯 N-苯甲酰甘氨酸鹽
|
1137608-69-5
|
|
Regorafenib
|
瑞格非尼
|
755037-03-7
|
|
Ciprofloxacin EP Impurity E
|
環(huán)丙沙星雜質(zhì)E
|
105394-83-0
|
|
Rifabutin
|
利福布汀
|
72559-06-9
|
|
Rifabutin EP Impurity D
|
3-氨基-4-亞氨基-利福霉素 S
|
62041-01-4
|
|
Oxyresveratrol 2-O-β-D-glucopyranoside
|
氧化白藜蘆醇-2-O-Β-D-吡喃葡萄糖苷
|
392274-22-5
|
|
9-Piperazino Ofloxacin
|
氧氟沙星EP雜質(zhì)D
|
197291-75-1
|
|
Tirapazamine
|
替拉扎明
|
27314-97-2
|
|
Mitoxantrone
|
米托蒽醌
|
65271-80-9
|
|
Ametantrone
|
阿美蒽醌
|
64862-96-0
|
|
Oxyresveratrol 3'-O-β-D-glucopyranoside
|
氧化白藜蘆醇-3'-O-Β-D-吡喃葡萄糖苷
|
144525-40-6
|
|
Riboflavin, 2',3',4',5'-tetraacetate
|
核黃素四乙酸酯
|
752-13-6
|
|
Amonafide
|
氨萘非特
|
69408-81-7
|
|
Pirarubicin
|
吡柔比星
|
72496-41-4
|
|
2,2'-(2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-4,5-diyl)bis(propan-2-ol)
|
奧美沙坦酯雜質(zhì)
|
1418133-29-5
|
|
Dimethyl 2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-4,5-dicarboxylate
|
奧美沙坦酯雜質(zhì)R
|
144690-53-9
|
|
CU-CPT-9b
|
CU-CPT-9B, CPD2004
|
2165340-32-7
|
|
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-methoxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate
|
奧美沙坦酯雜質(zhì)
|
1040405-56-8
|
|
1-(4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazol-5-yl)ethanone
|
奧美沙坦雜質(zhì)3
|
1227626-50-7
|
|
CPI-1189
|
N-叔丁基-4-乙酰氨基苯甲酰胺
|
183619-38-7
|
|
CU-CPT-9a
|
CPD1577
|
2162962-69-6
|
|
Necrostatin-1
|
NECROSTATIN-1
|
4311-88-0
|
|
CU-CPT-8m
|
CPD1578
|
125079-83-6
|
|
Raxatrigine
|
GSK1014802
|
934240-30-9
|
|
CPI-637
|
(R)-4-甲基-6-(1-甲基-3-(1-甲基-1H-吡唑-4-基)-1H-吲唑-5-基)-4,5-二氫-1H-苯并[B][1,4]二氮雜-2(3H)-酮
|
1884712-47-3
|
|
Zofenopril Calcium Salt
|
佐芬普利鈣
|
81938-43-4
|
|
Radotinib
|
拉多替尼
|
926037-48-1
|
|
BI-847325
|
BI-847325
|
1207293-36-4
|
|
Asciminib
|
ABL-001
|
1492952-76-7
|
|
CPI-203
|
CPI-203
|
1446144-04-2
|
|
Mivebresib
|
米維布塞
|
1445993-26-9
|
|
5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzylidene)thiazolidine-2,4-dione
|
5-[[4-[2-(5-乙基-2-吡啶基)-乙氧基]苯基]亞甲基]-2,4-噻唑烷二酮
|
144809-28-9
|
|
PFI-3
|
(2E)-1-(2-羥基苯基)-3-[(1R,4R)-5-(2-吡啶基)-2,5-二氮雜雙環(huán)[2.2.1]庚-2-基]-2-丙烯-1-酮
|
1819363-80-8
|
|
Tozasertib
|
陶扎色替
|
639089-54-6
|
|
PD-173955
|
6-(2,6-二氯苯基)-8-甲基-2-[[3-(甲硫基)苯基]氨基]吡啶并[2,3-D]嘧啶-7(8H)-酮
|
260415-63-2
|
|
WHI-P180
|
3-[(6,7-二甲氧基-4-喹唑啉基)氨基]苯酚
|
211555-08-7
|
|
SB1317
|
SB1317(混合異構(gòu))
|
1204918-72-8
|
|
Milciclib
|
PHA-848125
|
802539-81-7
|
|
Vildagliptin
|
維格列汀
|
274901-16-5
|
|
ONO-4059 (hydrochloride)
|
ONO-4059 (HYDROCHLORIDE)
|
1439901-97-9
|
|
CGI1746
|
N-[3-[4,5-二氫-4-甲基-6-[[4-(4-嗎啉基羰基)苯基]氨基]-5-氧代-2-吡嗪基]-2-甲基苯基]-4-(叔丁基)苯甲酰胺
|
910232-84-7
|
|
PLX-647
|
10MG
|
873786-09-5
|
|
Palbociclib Isethionate
|
帕布昔利布羥乙基磺酸鹽
|
827022-33-3
|
|
Methyl 13-cis-4-Oxoretinoate
|
4-KETO 13-CIS-RETINOIC ACID
|
71748-57-7
|
|
ICEC-0942
|
PPDA-001
|
1805833-75-3
|
|
RGB-286638 Free base
|
N-[1,4-二氫-3-[4-[[4-(2-甲氧基乙基)-1-哌嗪基]甲基]苯基]-4-氧代茚并[1,2-C]吡唑-5-基]-N'-4-嗎啉基脲
|
784210-88-4
|
|
AT7519 HCl
|
N-(4-哌啶基)-4-(2,6-二氯芐氨基)-1H-吡唑-3-羧胺鹽酸鹽
|
902135-91-5
|
|
Altiratinib
|
ALTIRATINIB
|
1345847-93-9
|
|
BML-277
|
2-(4-(4-CHLOROPHENOXY)PHENYL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXAMIDE
|
516480-79-8
|
|
OSI-930
|
3-[(4-喹啉甲基)氨基]-N-[4-(三氟甲氧基)苯基]-2-噻吩甲酰胺
|
728033-96-3
|
|
MSC2530818
|
MSC2530818
|
1883423-59-3
|
|
Motesanib Diphosphate
|
二磷酸莫替沙尼
|
857876-30-3
|
|
Dovitinib
|
4-氨基-5-氟-3-[5-(4-甲基哌嗪-1-基)-1H-苯并咪唑-2-基]喹啉-2(1H)-酮
|
405169-16-6
|
|
Motesanib
|
莫特塞尼
|
453562-69-1
|
|
BS-181 HCl
|
BS181
|
1397219-81-6
|
|
Golvatinib
|
N-[2-氟-4-[[2-[[[4-(4-甲基哌嗪-1-基)哌啶-1-基]羰基]氨基]吡啶-4-基]氧基]苯基]-N'-(4-氟苯基)環(huán)丙烷-1,1-二甲酰胺
|
928037-13-2
|
|
(S)-Viloxazine Hydrochloride
|
(S)-維洛沙嗪鹽酸鹽
|
56287-61-7
|
|
Simvastatin EP Impurity J
|
辛伐他汀4'-甲基醚
|
864357-88-0
|
|
Simvastatin EP Impurity C
|
辛伐他汀雜質(zhì)C
|
210980-68-0
|
|
1β-doxercalciferol
|
1BETA-羥基維他命D2
|
127516-23-8
|
|
1α-Hydroxy VD4
|
1ALPHA-羥基維生素 D4
|
143032-85-3
|
|
Simvastatin EP Impurity I
|
辛伐他汀雜質(zhì)I
|
79902-42-4
|
|
A-674563
|
A-674563
|
552325-73-2
|
|
1β-eldecalcitol
|
2Α-(3-羥丙基)氧基-1Α,25-二羥基維生素D3
|
158689-03-3
|
|
Simvastatin EP Impurity F
|
辛伐他汀雜質(zhì)F
|
79952-44-6
|
|
CH5424802 Hydrochloride
|
艾樂替尼鹽酸鹽
|
1256589-74-8
|
|
Alfacalcidol EP Impurity A
|
阿法骨化醇EP雜質(zhì)A
|
65445-14-9
|
|
25-Hydroxy Vitamin D3 3,3'-Aminopropyl Ether
|
25 - 羥基維生素D33,3' - 氨基丙基醚
|
163018-26-6
|
|
Calcium N5-methyltetrahydrofolate
|
5-甲基四氫葉酸鈣
|
26560-38-3
|
|
BAY-1895344
|
BAY-1895344
|
1876467-74-1
|
|
1,3-bi-TBS-trans-Alfacalcidol
|
阿爾法骨化醇中間體
|
112670-85-6
|
|
Eldecalcitol Intermediate CD
|
艾地骨化醇中間體CD環(huán)
|
144848-24-8
|
|
25-Hydroxyprovitamin D3
|
25-羥基-7-脫氫膽固醇
|
22145-68-2
|
|
9β,10α-cholesta-5,7-diene-3β,25-diol
|
25-HydroxyluMisterol3
|
61585-29-3
|
|
Eldecalcitol Intermediate A
|
艾地骨化醇中間體A環(huán)
|
200636-54-0
|
|
Alfacalcidol EP Impurity B
|
(1R,3R,Z)-5 - ((E)-2 - ((1R,7AR)-7A-甲基 - 1 - ((R)-
|
63181-13-5
|
|
Sertraline 2,3-Dichloro Ketone Impurity
|
舍曲林雜質(zhì)
|
152448-80-1
|
|
Defluoro Levofloxacin
|
左氧氟沙星去氟代雜質(zhì)
|
117620-85-6
|
|
Trospium Chloride Related Compound B
|
ALPHA-羥基-ALPHA-苯基苯乙酸 (3-內(nèi)型)-8-氮雜雙環(huán)[3.2.1]辛-3-基酯鹽酸鹽
|
63516-30-3
|
|
(3S,4S)-Tofacitinib
|
(3S,4S)-托法替尼
|
1092578-47-6
|
|
(3S,4R)-Tofacitinib
|
(3S,4R)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-BETA-氧代-1-哌啶丙腈
|
1092578-48-7
|
|
(3R,4R)-1-Benzyl-3-(methylamino)-4-methylpiperidine Dihydrochloride
|
(3R,4R)-N,4-二甲基-1-(苯基甲基)-3-哌啶胺鹽酸鹽
|
1062580-52-2
|
|
(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
|
(3S,4S)-1-芐基-N,4-二甲基哌啶-3-胺
|
1354486-07-9
|
|
(3S,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine
|
托法替尼雜質(zhì) H
|
1638499-33-8
|
|
(3R,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine
|
托法替尼雜質(zhì)62
|
1638499-31-6
|
|
Verapamil Impurity J HCl
|
鹽酸去甲維拉帕米
|
67812-42-4
|
|
OICR 9429
|
OICR-9429
|
1801787-56-3
|
|
(R)-Viloxazine Hydrochloride
|
(R)-維洛沙嗪鹽酸鹽
|
56287-63-9
|
|
15-Keto Travoprost
|
15-KETO-曲伏前列素
|
404830-45-1
|
|
Atorvastatin USP Related Compound E
|
阿托伐他汀相關(guān)物質(zhì)E
|
1105067-88-6
|
|
Atorvastatin USP Related Compound A
|
阿托伐他汀雜質(zhì)A
|
433289-83-9
|
|
N-Desmethyl Vandetanib
|
N-去甲基凡德他尼
|
338992-12-4
|
|
Ehp-inhibitor-1
|
化合物EHP-INHIBITOR-1
|
861249-59-4
|
|
BMS-794833
|
BMS-794833
|
1174046-72-0
|
|
Crizotinib
|
克唑替尼
|
877399-52-5
|
|
Lys05
|
Lys05
|
1391426-24-6
|
|
foretinib
|
N-[3-氟-4-[[6-甲氧基-7-[[3-(嗎啉-4-基)丙基]氧]喹啉-4-基]氧]苯基]-N'-(4-氟苯基)環(huán)丙烷-1,1-二甲酰胺
|
849217-64-7
|
|
Savolitinib
|
沃利替尼
|
1313725-88-0
|
|
Ehp-inhibitor-2
|
3-(7-amino-3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidin-6-yl)phenol
|
861249-77-6
|
|
EPZ-6438
|
EPZ-6438
|
1403254-99-8
|